If I Wasn’t a Scientific Entrepreneur, We Wouldn’t Have Enabled the Pfizer/BioNTech COVID-19 Vaccine

During the inaugural NMIN Lecture, Dr. Pieter Cullis will speak to the history of the research that led to the lipid nanoparticle (LNP) delivery system enabling the Pfizer/BioNTech COVID-19 vaccine, and why being a scientific entrepreneur was vital to this success.

He will also speak to future opportunities and challenges in nanomedicines, and suggest ways Canada can remain at the forefront of this field.